| VANCOUVER, BRITISH COLUMBIA--(Marketwire - March 28, 2012) - Response Biomedical Corporation (TSX:RBM)(OTCBB:RPBIF) today reported financial results for the year ending December 31, 2011. Financial results for the year ended 2011 Product sales of $9.0 million for the year ended December 31, 2011, compared to $6.8 million for the year ended December 31, 2010. Cardiovascular sales have increased to $7.3 million in 2011, compared to $6.0 million in 2010. An increase in sales to China was th...continued RBM:CA RPBIF Electronics Technology Electronics |
Wednesday, March 28, 2012
Response Biomedical Corporation Announces 2011 Financial Results
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment